1. Predictive factors of vascular intima media thickness in HIV-positive subjects.
- Author
-
Bongiovanni M, Casana M, Cicconi P, Pisacreta M, Codemo R, Pelucchi M, d'Arminio Monforte A, and Bini T
- Subjects
- Adult, Age Factors, Anti-HIV Agents administration & dosage, Antiretroviral Therapy, Highly Active, Cardiovascular Diseases etiology, Cardiovascular Diseases pathology, Cardiovascular Diseases prevention & control, Carotid Arteries diagnostic imaging, Female, Femoral Artery diagnostic imaging, Humans, Lipids blood, Logistic Models, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Sex Factors, Tunica Intima diagnostic imaging, Ultrasonography, Doppler, Color, Anti-HIV Agents therapeutic use, Carotid Arteries pathology, Femoral Artery pathology, HIV Infections complications, HIV Infections drug therapy, HIV Infections pathology, Tunica Intima pathology
- Abstract
Background: The predictive factors of intima media thickness (IMT) in the HIV-infected population are still poorly understood., Patients and Methods: We studied three groups of subjects, aged 30-50 years, to find potential predictive factors of carotid and/or femoral thickening (IMT > 1 mm in at least one area): healthy controls (G1, n = 54), HIV-infected naive (G2, n = 53) and highly active antiretroviral treatment (HAART)-treated subjects (G3, n = 133). All the subjects underwent ultrasonography of the carotid and femoral vessels to evaluate IMT., Results: Demographic characteristics of the three groups were comparable, except for gender (G1 had a higher percentage of females) and lipid levels (higher in G3). A total of 115 subjects (47.9%) had carotid and/or femoral IMT: 26 in G1 (48.1%), 21 in G2 (39.6%) and 68 in G3 (51.1%). Independent predictive factors of carotid and/or femoral IMT were older age (OR: 2.81, 95% CI: 1.95-4.04, P < 0.01, for each additional 5 years), triglycerides >or=150 mg/dL (OR: 2.66, 95% CI: 1.27-5.57, P < 0.001), serum glucose >or=110 mg/dL (OR: 5.24, 95% CI: 1.02-27.05, P = 0.04), high homocysteinaemia (OR: 2.75, 95% CI: 1.17-6.46, P = 0.02) and high body mass index (OR: 1.10, 95% CI: 1-1.22, P = 0.05 for each additional unit); females had a lower risk (OR: 0.38, 95% CI: 0.18-0.79, P < 0.01 versus males). HAART use was not associated with IMT (OR: 0.64, 95% CI: 0.27-1.53, P = 0.32 and OR: 0.80, 95% CI: 0.30-2.13, P = 0.20 for G3 and G2 versus G1, respectively)., Conclusions: This study demonstrates that traditional risk factors for cardiovascular diseases overshadow the role of HAART in determining premature vascular lesions.
- Published
- 2008
- Full Text
- View/download PDF